These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25155929)

  • 21. Pharmacogenetics and pharmacogenomics in rheumatology.
    Szekanecz Z; Meskó B; Poliska S; Váncsa A; Szamosi S; Végh E; Simkovics E; Laki J; Kurkó J; Besenyei T; Mikecz K; Glant TT; Nagy L
    Immunol Res; 2013 Jul; 56(2-3):325-33. PubMed ID: 23564183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetics and the impact on treatment protocols in patients with rheumatoid arthritis.
    Ibrahim I; Owen SA; Barton A
    Expert Rev Clin Immunol; 2012 Aug; 8(6):509-11. PubMed ID: 22992143
    [No Abstract]   [Full Text] [Related]  

  • 23. Testing pharmacogenetic indices to predict efficacy and toxicity of methotrexate monotherapy in a rheumatoid arthritis patient cohort.
    Owen SA; Lunt M; Hider SL; Bruce IN; Barton A; Thomson W
    Arthritis Rheum; 2010 Dec; 62(12):3827-9. PubMed ID: 20848569
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pharmacogenomics of methrotexate: a strategy for a customized therapeutic scheme for patients with rheumatoid arthritis].
    Mena-Ramírez JP; Salazar-Páramo M; Dávalos-Rodríguez IP
    Gac Med Mex; 2008; 144(5):449-51. PubMed ID: 19043967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential role of pharmacogenetics in anti-TNF treatment of rheumatoid arthritis and Crohn's disease.
    Kooloos WM; de Jong DJ; Huizinga TW; Guchelaar HJ
    Drug Discov Today; 2007 Feb; 12(3-4):125-31. PubMed ID: 17275732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis.
    Bek S; Bojesen AB; Nielsen JV; Sode J; Bank S; Vogel U; Andersen V
    Pharmacogenomics J; 2017 Oct; 17(5):403-411. PubMed ID: 28607508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenetics of etanercept in rheumatoid arthritis.
    Danila MI; Hughes LB; Bridges SL
    Pharmacogenomics; 2008 Aug; 9(8):1011-5. PubMed ID: 18681777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics.
    Conti V; Corbi G; Costantino M; De Bellis E; Manzo V; Sellitto C; Stefanelli B; Colucci F; Filippelli A
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33327600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Personalized medicine in rheumatoid arthritis: hopes and challenges.
    Bridges SL
    Bull NYU Hosp Jt Dis; 2007; 65(3):174-7. PubMed ID: 17922665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmacogenetics of methotrexate.
    Hider SL; Bruce IN; Thomson W
    Rheumatology (Oxford); 2007 Oct; 46(10):1520-4. PubMed ID: 17586865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The importance of pharmacogenetic tests in evaluation of the effectiveness of methotrexate treatment in rheumatoid arthritis (part 2)].
    Swierkot J; Slęzak R
    Postepy Hig Med Dosw (Online); 2011 Mar; 65():207-15. PubMed ID: 21502697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses.
    Behrens F; Koehm M; Burkhardt H
    Curr Opin Rheumatol; 2011 May; 23(3):282-7. PubMed ID: 21427581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-17, now an important target for treatment in arthritis!
    Miossec P
    Joint Bone Spine; 2017 May; 84(3):247-249. PubMed ID: 28017822
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacogenetics of disease-modifying anti-rheumatic drugs.
    Tanaka E; Taniguchi A; Urano W; Yamanaka H; Kamatani N
    Best Pract Res Clin Rheumatol; 2004 Apr; 18(2):233-47. PubMed ID: 15121042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenomics of tumor necrosis factor antagonists in rheumatoid arthritis.
    Ranganathan P
    Pharmacogenomics; 2005 Jul; 6(5):481-90. PubMed ID: 16013998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current concepts in the genetic diagnostics of rheumatoid arthritis.
    Nagy ZB; Csanád M; Tóth K; Börzsönyi B; Demendi C; Rigó J; Joó JG
    Expert Rev Mol Diagn; 2010 Jul; 10(5):603-18. PubMed ID: 20629510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leveraging human genetics to develop future therapeutic strategies in rheumatoid arthritis.
    Plenge RM; Raychaudhuri S
    Rheum Dis Clin North Am; 2010 May; 36(2):259-70. PubMed ID: 20510233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rheumatoid arthritis pharmacogenomics.
    Marsal S; Julià A
    Pharmacogenomics; 2010 May; 11(5):617-9. PubMed ID: 20415547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methotrexate pharmacogenetics: the first step toward individualized therapy in rheumatoid arthritis.
    Ranganathan P; McLeod HL
    Arthritis Rheum; 2006 May; 54(5):1366-77. PubMed ID: 16645965
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification of baseline gene expression signatures predicting therapeutic responses to three biologic agents in rheumatoid arthritis: a retrospective observational study.
    Nakamura S; Suzuki K; Iijima H; Hata Y; Lim CR; Ishizawa Y; Kameda H; Amano K; Matsubara K; Matoba R; Takeuchi T
    Arthritis Res Ther; 2016 Jul; 18():159. PubMed ID: 27435242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.